4WNV

Human Cytochrome P450 2D6 Quinine Complex

External Resource: Annotation

Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	Cytochrome P450	8068683	3001061	SCOP2B (2022-06-29)
B	SCOP2B Superfamily	Cytochrome P450	8068683	3001061	SCOP2B (2022-06-29)
C	SCOP2B Superfamily	Cytochrome P450	8068683	3001061	SCOP2B (2022-06-29)
D	SCOP2B Superfamily	Cytochrome P450	8068683	3001061	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	p450	e4wnvA1	A: alpha arrays	X: Cytochrome P450 (From Topology)	H: Cytochrome P450 (From Topology)	T: Cytochrome P450	F: p450	ECOD (1.6)
B	p450	e4wnvB1	A: alpha arrays	X: Cytochrome P450 (From Topology)	H: Cytochrome P450 (From Topology)	T: Cytochrome P450	F: p450	ECOD (1.6)
C	p450	e4wnvC1	A: alpha arrays	X: Cytochrome P450 (From Topology)	H: Cytochrome P450 (From Topology)	T: Cytochrome P450	F: p450	ECOD (1.6)
D	p450	e4wnvD1	A: alpha arrays	X: Cytochrome P450 (From Topology)	H: Cytochrome P450 (From Topology)	T: Cytochrome P450	F: p450	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	1.10.630.10	Mainly Alpha	Orthogonal Bundle	Cytochrome p450	Cytochrome P450	CATH (4.3.0)
B	1.10.630.10	Mainly Alpha	Orthogonal Bundle	Cytochrome p450	Cytochrome P450	CATH (4.3.0)
C	1.10.630.10	Mainly Alpha	Orthogonal Bundle	Cytochrome p450	Cytochrome P450	CATH (4.3.0)
D	1.10.630.10	Mainly Alpha	Orthogonal Bundle	Cytochrome p450	Cytochrome P450	CATH (4.3.0)

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B, C, D	Cytochrome P450 2D6	oxidoreductase activity catalytic activity monooxygenase activity anandamide 8,9 epoxidase activity oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen anandamide epoxidase activity anandamide 11,12 epoxidase activity anandamide 14,15 epoxidase activity binding organic cyclic compound binding tetrapyrrole binding heme binding cation binding oxidoreductase activity catalytic activity monooxygenase activity anandamide 8,9 epoxidase activity oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen anandamide epoxidase activity anandamide 11,12 epoxidase activity anandamide 14,15 epoxidase activity binding organic cyclic compound binding tetrapyrrole binding heme binding cation binding transition metal ion binding iron ion binding ion binding metal ion binding small molecule binding oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	oxidative demethylation demethylation metabolic process cellular process regulation of molecular function negative regulation of binding regulation of binding biological regulation negative regulation of molecular function catabolic process alkaloid catabolic process alkaloid metabolic process phenylpropanoid metabolic process coumarin metabolic process oxidative demethylation demethylation metabolic process cellular process regulation of molecular function negative regulation of binding regulation of binding biological regulation negative regulation of molecular function catabolic process alkaloid catabolic process alkaloid metabolic process phenylpropanoid metabolic process coumarin metabolic process secondary metabolic process estrogen metabolic process regulation of hormone levels steroid metabolic process primary metabolic process regulation of biological quality hormone metabolic process lipid metabolic process organic hydroxy compound metabolic process sterol metabolic process cholesterol metabolic process alcohol metabolic process secondary alcohol metabolic process small molecule metabolic process regulation of biological process regulation of cellular process negative regulation of organohalogen metabolic process negative regulation of metabolic process negative regulation of biological process negative regulation of organofluorine metabolic process regulation of organohalogen metabolic process organohalogen metabolic process organofluorine metabolic process negative regulation of cellular process regulation of organofluorine metabolic process regulation of metabolic process cellular response to stimulus cellular response to chemical stimulus response to stimulus response to chemical cellular response to xenobiotic stimulus xenobiotic metabolic process response to xenobiotic stimulus xenobiotic catabolic process icosanoid metabolic process fatty acid metabolic process long-chain fatty acid metabolic process unsaturated fatty acid metabolic process oxoacid metabolic process arachidonate metabolic process carboxylic acid metabolic process organic acid metabolic process olefinic compound metabolic process monocarboxylic acid metabolic process monocarboxylic acid biosynthetic process small molecule biosynthetic process long-chain fatty acid biosynthetic process lipid biosynthetic process organic acid biosynthetic process fatty acid biosynthetic process carboxylic acid biosynthetic process biosynthetic process isoquinoline alkaloid metabolic process monoterpenoid metabolic process terpenoid metabolic process isoprenoid metabolic process diterpenoid metabolic process retinoid metabolic process retinol metabolic process primary alcohol metabolic process	membrane-bounded organelle intracellular organelle cellular anatomical structure intracellular anatomical structure mitochondrion organelle cytoplasm intracellular membrane-bounded organelle organelle subcompartment membrane endomembrane system endoplasmic reticulum subcompartment nuclear outer membrane-endoplasmic reticulum membrane network endoplasmic reticulum membrane-bounded organelle intracellular organelle cellular anatomical structure intracellular anatomical structure mitochondrion organelle cytoplasm intracellular membrane-bounded organelle organelle subcompartment membrane endomembrane system endoplasmic reticulum subcompartment nuclear outer membrane-endoplasmic reticulum membrane network endoplasmic reticulum organelle membrane endoplasmic reticulum membrane

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B, C, D	IPR002401	Cytochrome P450, E-class, group I	Family
A, B, C, D	IPR017972	Cytochrome P450, conserved site	Conserved Site
A, B, C, D	IPR008069	Cytochrome P450, E-class, group I, CYP2D-like	Family
A, B, C, D	IPR050182	Cytochrome P450 family 2	Family
A, B, C, D	IPR001128	Cytochrome P450	Family
A, B, C, D	IPR036396	Cytochrome P450 superfamily	Homologous Superfamily

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B, C, D	Pharos: P10635	Alzheimer disease Drug Metabolism, Poor, Cyp2D6-Related hypoactive sexual desire disorder manganese poisoning dystonic disorder basal ganglia disease breast carcinoma amphetamine abuse epilepsy with generalized tonic-clonic seizures interstitial nephritis Parkinson disease schizophrenia diabetes mellitus substance-related disorder neuronal ceroid lipofuscinosis 2 Alzheimer disease Drug Metabolism, Poor, Cyp2D6-Related hypoactive sexual desire disorder manganese poisoning dystonic disorder basal ganglia disease breast carcinoma amphetamine abuse epilepsy with generalized tonic-clonic seizures interstitial nephritis Parkinson disease schizophrenia diabetes mellitus substance-related disorder neuronal ceroid lipofuscinosis 2 major depressive disorder substance dependence atrial fibrillation malaria substance abuse depressive disorder drug dependence acute kidney failure Tourette syndrome autism spectrum disorder breast cancer

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.